Autres langues CS Diagnostics Corp.

Actions

CSDX

US33852L2025

Equipement, fournitures et distribution médicale

Marché Fermé - OTC Markets 21:12:31 04/06/2026			Varia. 5j.	Varia. 1 janv.
0,0650 ^USD	-4,41%		+124,14%	-78,75%

15/04	CS Diagnostics Corp. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI
15/04	CS Diagnostics Corp. : l'auditeur émet des doutes sur la continuité de l'exploitation	CI

Autres langues

20/04	MicroCap Movers: ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, MMCP in the News
15/04	CS Diagnostics Corp. Reports Earnings Results for the Full Year Ended December 31, 2025
15/04	CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt
12/03	Medical Technology Alert: BSX, TFX, ARAY, CSDX, NDRA Emerging Across Cancer Treatment and GLP-1 Healthcare Ecosystems
05/03	Growth Stocks: NGTF, AMLM, CSDX, OTLC, ECGI Across Robotics, Precious Metals, MedTech and Blockchain
11/02	CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
29/01	CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products
27/01	MedTech: CS Diagnostics (OTCQB: CSDX): at the Crossroads of Infection Control and Oncology Innovation
27/01	MicroCap Watch 2026: BMXI, MATAF, ADMQ, CSDX, BCBC Asset-Driven and Revenue-Based Catalysts
21/01	CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP
14/01	Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside: ADMQ, BMXI, CSDX, SIGL
13/11	CS Diagnostics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	CS Diagnostics Corp. (OTCQB: CSDX) Aligns Capital and Structure for 2026 Expansion
09/10/25	CS Diagnostics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
29/07/25	CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt
22/07/25	CS Diagnostics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025
24/06/25	CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th
22/04/25	CS Group Announces the Valuation of MEDUSA Surface Disinfectant at USD 513 Million
15/04/25	CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS
27/03/25	Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment
18/03/25	CS Diagnostics (OTCQB: CSDX) CS-Protect Hydrogel FDA Approval on Fasttrack - GNPX, BON, SES, BETRF - Stocks to Watch Now!
12/03/25	OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval
19/02/25	"Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building"
23/01/25	Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
21/01/25	CS Diagnostics Corp. Announces U.S. Launch of MEDUSA